CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 89 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $3,659,000 | +63.4% | 30,897 | +41.0% | 0.02% | +45.5% |
Q2 2020 | $2,239,000 | +45.8% | 21,912 | +53.9% | 0.01% | +10.0% |
Q1 2020 | $1,536,000 | -91.5% | 14,234 | -90.8% | 0.01% | -83.3% |
Q4 2019 | $18,103,000 | +143.0% | 155,561 | +139.0% | 0.06% | +114.3% |
Q3 2019 | $7,451,000 | +62.2% | 65,092 | +7.5% | 0.03% | +40.0% |
Q4 2018 | $4,595,000 | +6.1% | 60,540 | +11.9% | 0.02% | +25.0% |
Q3 2018 | $4,330,000 | -45.5% | 54,120 | -32.4% | 0.02% | -51.5% |
Q2 2018 | $7,950,000 | – | 80,037 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Maso Capital Partners Ltd | 627,111 | $74,068,000 | 20.20% |
Athos Capital Ltd | 362,909 | $42,863,000 | 11.81% |
PSquared Asset Management AG | 205,000 | $24,213,000 | 3.85% |
York Capital Management Global Advisors, LLC | 302,675 | $35,749,000 | 3.52% |
HHLR ADVISORS, LTD. | 2,962,076 | $349,851,000 | 2.78% |
ALPINE ASSOCIATES MANAGEMENT INC. | 534,180 | $63,092,000 | 2.58% |
Pentwater Capital Management LP | 1,178,000 | $139,134,000 | 1.68% |
Temasek Holdings (Private) Ltd | 1,240,000 | $146,456,000 | 0.63% |
AQR Arbitrage LLC | 142,733 | $16,858,000 | 0.59% |
FORT, L.P. | 9,761 | $1,153,000 | 0.34% |